Implication of malignancy and prognosis of p27kip1, cyclin E, and cdk2 expression in epithelial ovarian tumors

Gynecologic Oncology

Volumn 83, Issue 1, 2001, Pages 56-63

  Sui, Li ^a   Dong, Youyi ^a   Ohno, Masayuki ^a   Sugimoto, Katsuyoshi ^a   Tai, Yuji ^a   Hando, Tamotsu ^a   Tokuda, Masaaki ^a  

^a KAGAWA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD2 ANTIGEN; CYCLIN E; PROTEIN P27;

ARTICLE; CANCER DIAGNOSIS; CANCER SURVIVAL; CELL CYCLE G1 PHASE; EPITHELIUM TUMOR; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; OVARY TUMOR; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SURVIVAL RATE; TUMOR GROWTH;

EID: 0034791332     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.2001.6308     Document Type: Article

References (39)

1. The epidemiology of ovarian cancer
2. Management of early ovarian cancer
3. Chemotherapy of advanced ovarian cancer
4. The prognostic significance of residual disease, FIGO substage, tumor histology, and grade in patients with FIGO stage III ovarian cancer
5. Cell cycle and cancer: Critical events at the G1 restriction point
6. Cancer cell cycle
7. G1 phase progression: Cycling on cue
8. The retinoblastoma protein and cell cycle control
9. Cloning of p57KIP2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution
10. Inhibitors of mammalian G1 cyclin dependent kinases
11. Cyclin gene amplification and overexpression in breast and ovarian cancers: Evidence for the selection of cyclin D1 in breast and cyclin E in ovarian tumors
12. Overexpression of cyclin D1 in epithelial ovarian cancers
13. Expression of cyclin D1 correlates with malignancy in human ovarian tumours
14. Altered expression of cyclin D1 and CDK4 genes in ovarian carcinomas
15. Analysis of cyclin E and CDK2 in ovarian cancer: Gene amplification and RNA overexpression
16. Expression and subcellular localization of cyclin D1 protein in epithelial ovarian tumour cells
17. Increased cyclin D1 expression is associated with features of malignancy and disease recurrence in ovarian tumors
18. KIP1 is a new prognostic marker associated with survival in epithelial ovarian tumors
19. Frequent loss of expression of the cyclin-dependent kinase inhibitor p27 in epithelial ovarian cancer
20. kip1 expression is associated with clinical outcome in advanced epithelial ovarian cancer: Multivariate analysis
21. Lack of independent prognostic significance of p21 and p27 expression in advanced ovarian cancer: An immunohistochemical study
22. kip1 and cyclin D1 in epithelial ovarian tumors
23. Inverse expression of cdk4 and p16 in epithelial ovarian tumors
24. kip1 and Ki-67 in benign and malignant thyroid tumors
25. Immunohistochemical analysis of p27/kip1 expression in thyroid carcinoma
26. kip1 expression in endocrine and other tumors
27. KIP1 in human lung cancers: Differential changes in small cell and non-small cell carcinomas
28. Kip1 protein: Prognostic implications in primary breast cancer
29. Prognostic role of the cyclin-dependent kinase inhibitor p27 in non-small cell lung cancer
30. p27 expression and gastric carcinoma
31. Kip1 and cyclin E, alone and in combination, correlate with survival in young breast cancer patients
32. Low p27 expression predicts poor disease-free survival in patients with prostate cancer
33. Cyclin E overexpression, a negative prognostic factor in breast cancer with strong correlation to oestrogen receptor status
34. Prognostic value of cyclin E and p53 expression in gastric carcinoma
35. Different expression patterns of cyclins A, D1 and E in human colorectal cancer
36. Concurrent amplification of cyclin E and cdk2 genes in colorectal carcinomas
37. Cyclin E, a potential prognostic marker for breast cancer
38. Immunohistochemical study of cyclins D and E and cyclin dependent kinase (cdk) 2 and 4 in human endometrial carcinoma
39. Analysis of cyclin E and CDK2 in ovarian cancer: Gene amplification and RNA overexpression